92 related articles for article (PubMed ID: 2777189)
21. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
Nagi DK; Ali VM; Yudkin JS
Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
[TBL] [Abstract][Full Text] [Related]
22. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
Reaven GM; Johnston P; Hollenbeck CB; Skowronski R; Zhang JC; Goldfine ID; Chen YD
J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
[TBL] [Abstract][Full Text] [Related]
23. Glycosylated haemoglobin, blood glucose and serum cholesterol levels in diabetics treated with guar gum.
Botha AP; Steyn AF; Esterhuysen AJ; Slabbert M
S Afr Med J; 1981 Mar; 59(10):333-4. PubMed ID: 7466486
[TBL] [Abstract][Full Text] [Related]
24. Guar and its effects on metabolic control in type II diabetic subjects.
Najemnik C; Kritz H; Irsigler K; Laube H; Knick B; Klimm HD; Wahl P; Vollmar J; Brauning C
Diabetes Care; 1984; 7(3):215-20. PubMed ID: 6376016
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic management of the secondary failure of sulfonylurea therapy].
Sauer H
Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
[No Abstract] [Full Text] [Related]
26. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
Mehnert H
Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
[No Abstract] [Full Text] [Related]
27. Therapeutic effect of guar gum in patients with non-insulin-dependent diabetes mellitus.
Chuang LM; Jou TS; Yang WS; Wu HP; Huang SH; Tai TY; Lin BJ
J Formos Med Assoc; 1992 Jan; 91(1):15-9. PubMed ID: 1352328
[TBL] [Abstract][Full Text] [Related]
28. Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes.
Aro A; Uusitupa M; Voutilainen E; Hersio K; Korhonen T; Siitonen O
Diabetologia; 1981 Jul; 21(1):29-33. PubMed ID: 6268475
[TBL] [Abstract][Full Text] [Related]
29. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men.
Landin K; Holm G; Tengborn L; Smith U
Am J Clin Nutr; 1992 Dec; 56(6):1061-5. PubMed ID: 1442658
[TBL] [Abstract][Full Text] [Related]
30. No glycemic benefit from guar administration in NIDDM.
Holman RR; Steemson J; Darling P; Turner RC
Diabetes Care; 1987; 10(1):68-71. PubMed ID: 3032537
[TBL] [Abstract][Full Text] [Related]
31. Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses.
Requejo F; Uttenthal LO; Bloom SR
Diabet Med; 1990 Jul; 7(6):515-20. PubMed ID: 2163805
[TBL] [Abstract][Full Text] [Related]
32. Moderate guar-gum addition to usual diet improves peripheral sensitivity to insulin and lipaemic profile in NIDDM.
Tagliaferro V; Cassader M; Bozzo C; Pisu E; Bruno A; Marena S; Cavallo-Perin P; Cravero L; Pagano G
Diabete Metab; 1985 Dec; 11(6):380-5. PubMed ID: 3002879
[TBL] [Abstract][Full Text] [Related]
33. Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patients.
Fuessl HS; Williams G; Adrian TE; Bloom SR
Diabet Med; 1987; 4(5):463-8. PubMed ID: 2959439
[TBL] [Abstract][Full Text] [Related]
34. Mortality risk with sulphonylureas compared to metformin.
Holden SE; Currie CJ
Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
[TBL] [Abstract][Full Text] [Related]
35. Influence of guar on serum lipids in patients with hyperlipidaemia.
Kirsten R; Domning B; Nelson K; Nemeth K; Oremek G; Hübner-Steiner U; Speck U
Eur J Clin Pharmacol; 1989; 37(2):117-20. PubMed ID: 2792165
[TBL] [Abstract][Full Text] [Related]
36. Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control.
Uusitupa M; Siitonen O; Savolainen K; Silvasti M; Penttilä I; Parviainen M
Am J Clin Nutr; 1989 Feb; 49(2):345-51. PubMed ID: 2537003
[TBL] [Abstract][Full Text] [Related]
37. Long-term treatment of hypercholesterolaemia with a new palatable formulation of guar gum.
Simons LA; Gayst S; Balasubramaniam S; Ruys J
Atherosclerosis; 1982 Oct; 45(1):101-8. PubMed ID: 6297516
[TBL] [Abstract][Full Text] [Related]
38. Treatment of familial hypercholesterolemia with a combination of bezafibrate and guar.
Wirth A; Middelhoff G; Braeuning C; Schlierf G
Atherosclerosis; 1982 Dec; 45(3):291-7. PubMed ID: 7159500
[TBL] [Abstract][Full Text] [Related]
39. Glycosylated haemoglobin, blood glucose and serum cholesterol levels in diabetics treated with guar gum.
Rosman MS
S Afr Med J; 1981 May; 59(21):739-40. PubMed ID: 7233285
[No Abstract] [Full Text] [Related]
40. Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia.
Uusitupa M; Ebeling T; Happonen P; Voutilainen E; Turtola H; Parviainen M; Pyörälä K
J Cardiovasc Pharmacol; 1991 Oct; 18(4):496-503. PubMed ID: 1724525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
